We recently published an article titled Market Slump Drags Down Share Prices of These 15 Companies. In this article, we…
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 4,213 shares of the stock in…
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Michael Chi sold 17,303 shares of the companys stock…
Hims & Hers health CFO sells shares worth $126,317…
Hims & Hers chief commercial officer sells $483,964 in stock…
Hims & Hers Health (NYSE:HIMS) Stock Price Down 6.1% - Time to Sell?…
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine…
Shares of Hims & Hers Health Inc (HIMS) fell 5.25% in mid-day trading on Dec 27. The stock reached an…
Hims & Hers Health (NYSE:HIMS) Stock Price Up 3.6% - Still a Buy?…
…
Hims & Hers Health (NYSE:HIMS) has had a great run on the share market with its stock up by a…
Hims & Hers Health, Inc. ( NYSE:HIMS ), is not the largest company out there, but it led the NYSE…
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Michael Chi sold 7,500 shares of the stock in…
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 18,959 shares of the companys stock…
The Short discusses a 15% drop in Hims & Hers stock following an FDA announcement ending the shortage of Eli…
The Short discusses a 15% drop in Hims & Hers stock following an FDA announcement ending the shortage of Eli…
Hims & Hers health chief commercial officer sells $195,000 in stock…
Hims & Hers health CFO sells $488,530 in stock…
Hims & Hers Health (NYSE:HIMS) Shares Gap Up - Still a Buy?…
Hims & Hers is transforming telehealth with personalized medications, rapid subscription growth, and strong financials, poised for market leadership. Read…
…
Hims & Hers stock price has greatly performed this year as it continued to disrupt the healthcare industry. HIMS has…
Geode Capital Management LLC boosted its position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 12.7%…
Barclays PLC grew its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 9.7%…
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…
Hims & Hers stock is full of noise, but whats the signal for investors?…
Hims & Hers stock is full of noise, but whats the signal for investors?…
Hims & Hers stock is full of noise, but whats the signal for investors?…
Franklin Resources Inc. trimmed its holdings in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 15.9% during…
Shares in Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc.…
Shares in Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc. (MSTR) posted significant declines on Thursday, dropping by…
Hims & Hers faces regulatory hurdles but shows strong business growth. Find out why HIMS stock is a "Hold" despite…
…
These are the stocks posting the largest moves in midday trading.…
Hims & Hers Health (HIMS) shares tumble after the US Food and Drug Administration (FDA) announced that the shortage in…
Hims & Hers Health, Inc. (NYSE: HIMS) are trading lower Thursday. The U.S. Food and Drug Administration (FDA) issued a…
Meine gestrige Vermutung hat sich bestätigt: Die FDA hat den Engpass von Tirzepatid offiziell für beendet erklärt. Gleichzeitig bleibt das…
Hims & Hers Health (NYSE:HIMS) Shares Gap Down - Heres Why…
Insider sales, FDA rulings, and sky-high valuations--why investors are split on telehealths rising star…
Shares of Hims & Hers Health, Inc. (NYSE: HIMS), the telehealth company known for offering wellness products and services, faced…
Insider sales, FDA rulings, and sky-high valuations--why investors are split on telehealths rising star…
Hims & Hers Health (NYSE:HIMS) is down 7% in early morning trading after the U.S. FDA determined that there is…
Hims & Hers shares tumble as FDA resolves obesity drug shortage…
Fmr LLC reduced its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 99.2%…